Drug and pharmaceutical recalls

DayQuil liquid (12/8oz bottles) distributed by Gold Star Distribution Inc. was stored in conditions that did not meet safety standards, including exposure to rodents at their distribution center. All unexpired lots distributed by this company are affected. No injuries have been reported.

DayQuil Cold & Flu 32-count twin packs distributed by Gold Star Distribution may have been stored in insanitary conditions with rodent activity at a distribution center. The FDA is recalling all lots still within their expiration date that were distributed nationwide.

Gold Star Distribution Inc. distributed Claritin 20-count tablets that were stored in conditions with rodent exposure and activity at their distribution center. The FDA found insanitary conditions that violate manufacturing standards. This affects all lots of this product distributed by Gold Star that are still within their expiration date.

Bayer products distributed by Gold Star Distribution Inc. were stored in conditions with rodent exposure and other sanitation issues at their distribution center. The FDA is recalling all lots that are still within their expiration date.

Gold Star Distribution Inc. distributed Benadryl 25-count 2-packs (UPC 815556020316) from a distribution center with insanitary conditions and evidence of rodent activity. The contamination risk affects all lots that were within expiration and distributed by this company across the United States.

Alka-Seltzer Original (58-count boxes) and Plus Cold & Flu (36-count boxes) distributed by Gold Star Distribution Inc. were stored in conditions with rodent exposure and activity. The FDA found unsanitary conditions at the distribution center that do not meet manufacturing safety standards.

Gold Star Distribution Inc. distributed Aleve 1's (60-count bottles) that were stored in conditions that did not meet safety standards. The distribution center had insanitary conditions and evidence of rodent activity. All unexpired lots distributed by this company are affected.

Advil Ibuprofen and Advil PM dispenser packs distributed by Gold Star Distribution Inc. were stored in conditions that did not meet safety standards, including rodent exposure at their distribution center. The affected products were distributed nationwide. No injuries have been reported.

Encon Safety Products is recalling specific lots of AQ 120 GFEW Aquarion Preserved Cartridges due to manufacturing process deviations that do not meet FDA standards. The cartridges were distributed nationwide. No injuries have been reported.

One bottle of Alvogen Thyro-Tabs 150mcg levothyroxine tablets (Lot MHA21825) was found to contain 88mcg tablets instead of the labeled 150mcg strength. This mix-up affects only a single bottle distributed nationwide. No injuries have been reported.

Advanced Pharmaceutical Technology is recalling TESTO-100 CIII testosterone pellets (Lot P-22-3, expiration 06-2027) because they may not be sterile and could be contaminated with harmful microbes. These are prescription implant pellets used for testosterone replacement therapy. The recall affects 22,843 pellets distributed in Georgia, New York, Texas, Puerto Rico, the United Kingdom, Malta, and Greece.

Sun Pharmaceutical has recalled three lots of clindamycin phosphate 1% topical solution due to failed quality tests. The affected batches contain higher-than-acceptable impurities and may not contain the correct amount of active ingredient, which could reduce effectiveness.

Taro Pharmaceuticals is recalling specific lots of fluocinolone acetonide topical solution (0.01%) because testing found higher-than-allowed levels of an impurity. The affected lots were distributed nationwide. No injuries have been reported.

AvKARE is recalling Rosuvastatin 10 mg tablets (Lot #49124, expiring 12/31/2026) because they don't dissolve properly in the body. This means the medication may not work as intended. No injuries have been reported so far.

ClearLife Allergy Nasal Spray Extra Strength has been found to contain yeast, mold, and a bacterium called Achromobacter. The contamination affects all batches still within their expiration date sold nationwide. No injuries have been reported so far.

MediNatura ReBoost Nasal Spray has been found to contain yeast, mold, and a bacterium called Achromobacter. These contaminants should not be in a nasal spray, which is meant to be sterile. The contamination affects all lots currently in use.

SpecGx LLC is recalling one lot of oxycodone and acetaminophen tablets (7.5 mg/325 mg) because some tablets may be missing the imprint (identifying mark). This makes it difficult to verify you have the correct medication. No injuries have been reported.

SpecGx LLC is recalling certain bottles of oxycodone and acetaminophen 10mg/325mg tablets because some tablets may be missing the imprint (marking). This could make it difficult to identify the medication. No injuries have been reported.

ORL Labs recalled ORL Kids Natural Toothpaste in Bubblegum Flavor due to deviations from manufacturing quality standards (cGMP). The affected product is Lot #250520P4 with expiration date 05/27, distributed in Arizona. No injuries have been reported.

ORL Kids Mouthwash in Bubblegum flavor did not meet FDA manufacturing standards during production. The issue affects 570 bottles distributed in Arizona with lot number 250505P9 and expiration date 05/27. No injuries have been reported.

Imprimis NJOF recalled Tri-Moxi+ eye injections because some batches contain glass-like particles. The affected batches (25JAN033A and 25JAN033B) expire in February 2026. No injuries have been reported.

Imprimis NJOF's dexamethasone-moxifloxacin-ketorolac eye injection contains glass-like particles that could contaminate the injection. This medication is used during eye surgery. The affected lots are 25APR001A and 25APR001B, expiring 04/03/2026.

Imprimis NJOF, LLC is recalling specific lots of Dexamethasone Moxifloxacin intraocular injection due to the presence of glass-like particles in the medication. This injection is used during eye surgery. Two affected lots have been identified and distributed nationwide.

Alembic Pharmaceuticals is recalling one lot of Fesoterodine Fumarate 8 mg extended-release tablets because testing found levels of a chemical impurity (diester impurity) that exceed safety limits. The affected lot is 2405003360, which expires January 31, 2026.

Zydus Pharmaceuticals is recalling certain bottles of trazodone 100mg tablets because some tablets have dents on the surface. The defect affects lot EA00237A with an expiration date of 04/30/2027. No injuries have been reported.

Glenmark Pharmaceuticals discovered that blister packs containing Ondansetron 4mg orally disintegrating tablets are not fully sealed, allowing tablets to fall out. The affected product was repackaged and distributed nationwide. This applies to lot #19251311 with an expiration date of April 2027.

Novo Nordisk has recalled specific batches of Wegovy (semaglutide) 1 mg injection pens because hair was found inside prefilled syringes. This affects two lot numbers distributed nationwide. No injuries have been reported.

Novo Nordisk discovered hair in some prefilled Wegovy injection pens. This affects specific lot numbers manufactured in Denmark. No injuries have been reported.

CareFusion 213, LLC is recalling BD ChloraPrep Triple Swabsticks (a skin antiseptic swab) because the manufacturer cannot confirm the product was properly sterilized. The affected lot (#5086623, expiring 3/31/2028) was distributed nationwide. No injuries have been reported.

Merck has recalled specific lots of Noxafil Powdermix, a prescription antifungal medication, because some packets may contain metal particles. This affects 845 kits distributed nationwide. No injuries have been reported.